[Experience using cefpirome in patients with infections of the bronchopulmonary system].
The clinical efficacy and tolerance of cefpirome were estimated in the treatment of patients with bacterial infection of the respiratory tract. The estimate included 15 patients with acute and chronic bronchopulmonary diseases: 6 patients with acute pneumonia, 5 with exacerbated chronic purulent obstructive bronchitis and 4 with primary immune deficiency (agammaglobulinemia and acute pneumonia). Excellent and good total efficacy of the drug was stated in 6 and 8 patients respectively. In 1 patient the treatment was discontinued because of acute urticaria. Therefore, cefpirome is to be recommended as a highly efficient agent for the treatment of bronchopulmonary infection.
Il'ina
N I
NI
Shul'zhenko
A E
AE
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000361:Agammaglobulinemia / Q000276:immunology; D001424:Bacterial Infections / Q000188:drug therapy* / Q000276:immunology; D001991:Bronchitis / Q000188:drug therapy* / Q000276:immunology; D002511:Cephalosporins / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D018410:Pneumonia, Bacterial / Q000188:drug therapy*; D016896:Treatment Outcome; D000097572:Cefpirome
D002511:Cephalosporins; D000097572:Cefpirome